GSK announces positive COPD trial results
6th Sep 2024 08:53
(Sharecast News) - GSK announced positive results from its phase three 'MATINEE' clinical trial on Friday, which evaluated the effectiveness of 'Nucala', or mepolizumab, in treating chronic obstructive pulmonary disease (COPD).
Read moreGSK;s RSV vaccine gets expanded approval in Europe
29th Aug 2024 07:18
(Sharecast News) - GSK announced on Thursday that the European Commission had granted approval for Arexvy, a respiratory syncytial virus (RSV) vaccine, to be used in adults aged 50 to 59 who were at heightened risk of severe RSV-related illness.
Read moreLondon close: Stocks slip as investors await Nvidia results
28th Aug 2024 15:00
(Sharecast News) - London stocks ended slightly down on Wednesday, with investors showing restraint ahead of crucial earnings from US chipmaker Nvidia.
Read moreShore Capital hails "another ray of light" at GSK after Zantac litigation update
28th Aug 2024 10:45
(Sharecast News) - Shore Capital has reiterated its 'buy' rating on GSK after the biopharma giant's latest update about its ongoing Zantac litigation, saying that the stock's valuation is still undemanding compared with the wider market.
Read moreGSK upbeat on Zantac litigation development, Japan approvals
28th Aug 2024 07:18
(Sharecast News) - GSK announced a number of developments on Wednesday, firstly welcoming a decision from the Delaware Supreme Court to review a lower court ruling that allowed the introduction of expert evidence in the ongoing litigation over 'Zantac', or ranitidine.
Read moreGSK lung cancer drug gets FDA breakthrough designation
20th Aug 2024 07:22
(Sharecast News) - Pharmaceutical giant GSK announced on Tuesday that the US Food and Drug Administration (FDA) has granted breakthrough therapy designation to its investigational drug, GSK5764227 (GSK'227), for the treatment of patients with extensive-stage small-cell lung cancer (ES-SCLC) who had experienced disease progression following platinum-based chemotherapy.
Read moreLondon close: Stocks slip on relatively quiet Friday
16th Aug 2024 17:46
(Sharecast News) - London's stock markets closed lower on Friday, weighed down by a stronger pound and mixed investor sentiment following the release of the latest UK retail sales figures.
Read moreGSK to seek dismissal of Zantac Florida case as court rejects testimony
16th Aug 2024 07:05
(Sharecast News) - UK pharma giant GSK has welcomed a US court ruling excluding expert testimony in the long-running Zantac lawsuit where the plaintiffs allege the heartburn drug caused cancer and said it would now ask for the case to be dismissed.
Read moreIllinois court rules in GSK's favour in Zantac case
6th Aug 2024 07:18
(Sharecast News) - GSK was upbeat after securing a legal victory in a case in the ongoing litigation surrounding its discontinued heartburn drug Zantac.
Read moreLondon close: Stocks join global slide on fears of US recession
2nd Aug 2024 14:57
(Sharecast News) - London stocks closed in negative territory on Friday as investors reacted to a weaker-than-expected non-farm payrolls report from the United States, indicating a sharp slowdown in hiring last month.
Read moreGSK's endometrial cancer drug gets expanded US approval
2nd Aug 2024 07:34
(Sharecast News) - GSK said the US Food and Drug Administration has approved its Jemperli treatment in combination with chemotherapy and then use on its own for adult patients with primary advanced or recurrent endometrial cancer.
Read moreLondon close: Stocks finish higher as miners pace gains
31st Jul 2024 15:04
(Sharecast News) - London's stock markets ended the day with strong gains on Wednesday, driven by robust performances in the mining and energy sectors.
Read moreGSK lifts guidance as Q2 sales beat forecasts
31st Jul 2024 07:37
(Sharecast News) - UK pharmaceutical company GSK raised annual forecasts after better-than-expected second-quarter results, driven by a strong performance from its cancer and HIV treatments.
Read moreGSK says RSV jab gets EU recommendation, settles Zantac case
29th Jul 2024 07:33
(Sharecast News) - GSK announced a significant development in its respiratory syncytial virus (RSV) vaccine portfolio on Monday, as well as a settlement to one of the Zantac cases.
Read moreLondon close: Stocks fall on day of global IT chaos
19th Jul 2024 17:08
(Sharecast News) - London's stock markets closed in the red on Friday, affected by a significant global IT outage and a drop in UK retail sales.
Read more